Robert Wills, Ph.D., currently serves as the Executive Chairman of GTx, Inc, Chairman
of the Board of CymaBay Therapeutics,
Board member at Parion Sciences, Inc, and
a member of the Emerging Companies Section Governing Board of BIO.
Prior to these roles, Dr. Wills spent over 25 years at Johnson & Johnson and 10 years at Hoffmann-LaRoche.
He holds a BS in Biochemistry, MS in Pharmaceutics from the University of Wisconsin and a PhD in Pharmaceutics from the University of Texas.
.svg)
